yh12852
Small moleculeexperimental
Clinical trial activity
4 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
3
Phase 2
2
Phase 3
0
Phase 4
0
Earliest trial started Aug 1, 2013 (NCT01870674)
Timeline
Indications
Mechanism of action
- 5-hydroxytryptamine receptorAGONIST
5-hydroxytryptamine receptor agonist
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- yh12852
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT03381703 | Phase 1 | Mar 16, 2017 | Seoul National University |
| NCT02567578 | Phase 2 | Oct 1, 2015 | Sungkyunkwan University, Yuhan Pharmaceutical Company |
| NCT02538367 | Phase 1/Phase 2 (Phase 2) | Aug 1, 2015 | Seoul National University, Yuhan Pharmaceutical Company |
| NCT01870674 | Phase 1 | Aug 1, 2013 | Yuhan Pharmaceutical Company |
Showing 4 of 4 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Yuhan Pharmaceutical Company | For profit | 3 | 3 | 2 | 2013 |
| Seoul National University | Academic/Hospital | 2 | 1 | 2 | 2015 |
| Sungkyunkwan University | Academic/Hospital | 1 | 0 | 1 | 2015 |
3 organizations
Page 1 / 1